Fortress Biotech, Inc.
FBIO
$2.72
$0.010.37%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -468.00K | 110.37M | -3.94M | 5.85M | 15.49M |
| Total Depreciation and Amortization | 1.06M | 1.22M | 1.16M | 1.16M | 1.16M |
| Total Amortization of Deferred Charges | 223.00K | 1.46M | 339.00K | 319.00K | 451.00K |
| Total Other Non-Cash Items | -6.46M | 35.02M | 702.00K | -8.90M | -37.17M |
| Change in Net Operating Assets | -53.64M | 55.79M | -10.81M | -4.53M | -7.48M |
| Cash from Operations | -59.28M | 203.85M | -12.54M | -6.11M | -27.56M |
| Capital Expenditure | -79.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 0.00 | 2.87M | 6.09M |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -79.00K | -- | 0.00 | 2.87M | 6.09M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 14.49M | -14.49M | 55.00K | -130.00K | 0.00 |
| Issuance of Common Stock | 232.00K | 1.44M | 412.00K | 1.80M | 618.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 0.00 | -14.34M | 0.00 | 0.00 | -115.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.64M | -- | 5.24M | 13.40M | 4.02M |
| Cash from Financing | 91.00K | -27.39M | 5.71M | 15.07M | 4.52M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -59.27M | 176.46M | -6.84M | 11.83M | -16.95M |